Want to see ENTX full AI Analyst Report?
Entera Bio (ENTX) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ebp05, Forteo 20 Mg, Ebp11, Ebp22 | Osteoporosis, Hypoparathyroidism, Fractures, Bone, Other Disease | phase1AndPhase2 | Active Not Recruiting | Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo | Jun 08, 2023 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ebp05, Forteo 20 Mg, Ebp11, Ebp22 | phase1AndPhase2 | Osteoporosis, Hypoparathyroidism, Fractures, Bone, Other Disease | Active Not Recruiting | Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo | Jun 08, 2023 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Entera Bio (ENTX) have in its pipeline
Entera Bio ENTX is currently developing the following drugs: Ebp05, Forteo 20 Mg, Ebp11, Ebp22. These drug candidates are in various stages of clinical development as the company works toward FDA approval.